Related Experiment Video

Updated: May 11, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Neurologic manifestations of chronic methamphetamine abuse

Daniel E Rusyniak1

  • 1Department of Emergency Medicine, Indiana University School of Medicine, 1050 Wishard Boulevard, Room 2200, Indianapolis, IN 46202, USA. drusynia@iupui.edu

The Psychiatric Clinics of North America
|May 22, 2013
PubMed

Insights

Methamphetamine (Meth) abuse significantly impacts psychiatry, causing addiction and psychiatric issues like psychosis. Understanding its neurological effects is crucial for effective treatment and managing the Meth epidemic.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Addiction Research

Background:

  • Methamphetamine is a potent psychostimulant with profound effects on brain chemistry.
  • Chronic methamphetamine use leads to significant neurotoxicity and psychiatric complications.
  • Addiction and psychosis are primary reasons individuals seek psychiatric care for methamphetamine abuse.

Purpose of the Study:

  • To elucidate the chronic neurological manifestations of methamphetamine abuse.
  • To enhance psychiatric practitioners' understanding of methamphetamine's impact.
  • To provide tools for diagnosing and treating methamphetamine-induced psychiatric disorders.

Main Methods:

  • Review of existing literature on methamphetamine's neurobiological effects.
  • Analysis of psychiatric case studies related to chronic methamphetamine use.
  • Synthesis of current diagnostic and therapeutic approaches.

Main Results:

  • Methamphetamine increases extracellular dopamine, damaging dopaminergic pathways.
  • Chronic use results in memory deficits, impaired executive function, anxiety, depression, and psychosis.
  • Addiction and psychosis are key indicators for psychiatric intervention.

Conclusions:

  • Understanding chronic neurological effects of methamphetamine is vital for psychiatric practice.
  • Effective diagnostic and therapeutic strategies can mitigate the impact of the methamphetamine epidemic.
  • Targeting neurotoxicity and psychiatric sequelae is essential for patient recovery.

More Related Videos

A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain12:31

A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain

Published on: November 14, 2012

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...